Literature DB >> 11702065

Dermal-resident CD14+ cells differentiate into Langerhans cells.

A T Larregina1, A E Morelli, L A Spencer, A J Logar, S C Watkins, A W Thomson, L D Falo.   

Abstract

Epidermal Langerhans cells (LCs) show extraordinary immunostimulatory capacity and play a key role in the initiation and regulation of immune responses. Studies of LC biology are currently the focus of efforts to engineer immune responses and to better understand the immunopathology of cutaneous diseases. Here we identified and characterized a population of LC precursors that were resident in human skin. These immediate precursors expressed CD14, langerin and functional CCR6. When cultured with transforming growth factor-beta1 alone, they had the potential to differentiate into epidermal LCs; when cultured in the presence of granulocyte macrophage-colony-stimulating factor and interleukin 4 they differentiated into functionally mature dendritic cells. Identification and characterization of these LC precursors provided insight into LC biology and the mechanism(s) through which LCs repopulate the epidermis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11702065     DOI: 10.1038/ni731

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  62 in total

1.  Langerhans cells renew in the skin throughout life under steady-state conditions.

Authors:  Miriam Merad; Markus G Manz; Holger Karsunky; Amy Wagers; Wendy Peters; Israel Charo; Irving L Weissman; Jason G Cyster; Edgar G Engleman
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

2.  Differences in T-helper polarizing capability between human monocyte-derived dendritic cells and monocyte-derived Langerhans'-like cells.

Authors:  Ivan Rajkovic; Ana Dragicevic; Sasa Vasilijic; Biljana Bozic; Tanja Dzopalic; Sergej Tomic; Ivana Majstorovic; Dragana Vucevic; Jelena Djokic; Bela Balint; Miodrag Colic
Journal:  Immunology       Date:  2010-10-13       Impact factor: 7.397

Review 3.  Professional antigen-presenting cells of the skin.

Authors:  Alicia R Mathers; Adriana T Larregina
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 4.  Dendritic cells and contact dermatitis.

Authors:  Yoshinori Sasaki; Setsuya Aiba
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

5.  "Dermal dendritic cells" comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages.

Authors:  Maria Teresa Ochoa; Anya Loncaric; Stephan R Krutzik; Todd C Becker; Robert L Modlin
Journal:  J Invest Dermatol       Date:  2008-03-13       Impact factor: 8.551

6.  Deepening our understanding of immune sentinels in the skin.

Authors:  Frank O Nestle; Brian J Nickoloff
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

7.  Reversal of human papillomavirus-specific T cell immune suppression through TLR agonist treatment of Langerhans cells exposed to human papillomavirus type 16.

Authors:  Laura M Fahey; Adam B Raff; Diane M Da Silva; W Martin Kast
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide.

Authors:  Yun-Chi Chen; Sheng-Yuan Wang
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network.

Authors:  Laurent Chorro; Aurélien Sarde; Mei Li; Kevin J Woollard; Pierre Chambon; Bernard Malissen; Adrien Kissenpfennig; Jean-Baptiste Barbaroux; Richard Groves; Frédéric Geissmann
Journal:  J Exp Med       Date:  2009-12-07       Impact factor: 14.307

10.  Signaling through purinergic receptors for ATP induces human cutaneous innate and adaptive Th17 responses: implications in the pathogenesis of psoriasis.

Authors:  Meaghan E Killeen; Laura Ferris; Erine A Kupetsky; Louis Falo; Alicia R Mathers
Journal:  J Immunol       Date:  2013-03-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.